Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Clinical relevance of TAp73 and ΔNp73 protein expression in ovarian cancer: a series of 83 cases and review of the literature.

Hofstetter G, Berger A, Chamson M, Müller-Holzner E, Reimer D, Ulmer H, Uramoto H, Marth C, Zeimet AG, Zeillinger R, Concin N.

Int J Gynecol Pathol. 2011 Nov;30(6):527-31. doi: 10.1097/PGP.0b013e31821ac519. Review. Erratum in: Int J Gynecol Pathol. 2012 May;31(3):296. G Zeimet, A [corrected to Zeimet, Alain G]. Int J Gynecol Pathol. 2012 Mar;31(2):191. Zeimet, Alain G [corrected to G Zeimet, A].

PMID:
21979586
[PubMed - indexed for MEDLINE]
2.

Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.

Concin N, Hofstetter G, Berger A, Gehmacher A, Reimer D, Watrowski R, Tong D, Schuster E, Hefler L, Heim K, Mueller-Holzner E, Marth C, Moll UM, Zeimet AG, Zeillinger R.

Clin Cancer Res. 2005 Dec 1;11(23):8372-83.

PMID:
16322298
[PubMed - indexed for MEDLINE]
Free Article
3.

Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.

Concin N, Becker K, Slade N, Erster S, Mueller-Holzner E, Ulmer H, Daxenbichler G, Zeimet A, Zeillinger R, Marth C, Moll UM.

Cancer Res. 2004 Apr 1;64(7):2449-60.

PMID:
15059898
[PubMed - indexed for MEDLINE]
Free Article
4.

Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression.

Saifudeen Z, Diavolitsis V, Stefkova J, Dipp S, Fan H, El-Dahr SS.

J Biol Chem. 2005 Jun 17;280(24):23094-102. Epub 2005 Apr 1.

PMID:
15805112
[PubMed - indexed for MEDLINE]
Free Article
5.

Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations.

Faridoni-Laurens L, Tourpin S, Alsafadi S, Barrois M, Temam S, Janot F, Koscielny S, Bosq J, Bénard J, Ahomadegbe JC.

Cell Cycle. 2008 Jun 1;7(11):1587-96. Epub 2008 Mar 2.

PMID:
18469517
[PubMed - indexed for MEDLINE]
Free Article
6.

Aberrant expression of DeltaNp73 in benign and malignant tumours of the prostate: correlation with Gleason score.

Guan M, Chen Y.

J Clin Pathol. 2005 Nov;58(11):1175-9.

PMID:
16254107
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

p73 expression in medulloblastoma: TAp73/DeltaNp73 transcript detection and possible association of p73alpha/DeltaNp73 immunoreactivity with survival.

Zitterbart K, Zavrelova I, Kadlecova J, Spesna R, Kratochvilova A, Pavelka Z, Sterba J.

Acta Neuropathol. 2007 Dec;114(6):641-50. Epub 2007 Oct 3. Erratum in: Acta Neuropathol. 2008 Nov;116(5):579-80.

PMID:
17912537
[PubMed - indexed for MEDLINE]
8.

DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1.

Domínguez G, García JM, Peña C, Silva J, García V, Martínez L, Maximiano C, Gómez ME, Rivera JA, García-Andrade C, Bonilla F.

J Clin Oncol. 2006 Feb 10;24(5):805-15. Epub 2005 Dec 27.

PMID:
16380414
[PubMed - indexed for MEDLINE]
9.

Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.

Marabese M, Marchini S, Marrazzo E, Mariani P, Cattaneo D, Fossati R, Compagnoni A, Signorelli M, Moll UM, Codegoni AM, Broggini M.

Eur J Cancer. 2008 Jan;44(1):131-41. Epub 2007 Nov 26.

PMID:
18039564
[PubMed - indexed for MEDLINE]
10.

Expression of the p53 family in lung cancer.

Uramoto H, Sugio K, Oyama T, Nakata S, Ono K, Nozoe T, Yasumoto K.

Anticancer Res. 2006 May-Jun;26(3A):1785-90.

PMID:
16827107
[PubMed - indexed for MEDLINE]
Free Article
11.

Overexpressed TP73 induces apoptosis in medulloblastoma.

Castellino RC, De Bortoli M, Lin LL, Skapura DG, Rajan JA, Adesina AM, Perlaky L, Irwin MS, Kim JY.

BMC Cancer. 2007 Jul 12;7:127.

PMID:
17626635
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Expression of deltaNp73 predicts poor prognosis in lung cancer.

Uramoto H, Sugio K, Oyama T, Nakata S, Ono K, Morita M, Funa K, Yasumoto K.

Clin Cancer Res. 2004 Oct 15;10(20):6905-11.

PMID:
15501968
[PubMed - indexed for MEDLINE]
Free Article
13.

DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.

Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, Pearl M, Chalas E, Moll UM.

J Exp Med. 2002 Sep 16;196(6):765-80.

PMID:
12235210
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Patterns of p73 N-terminal isoform expression and p53 status have prognostic value in gynecological cancers.

Becker K, Pancoska P, Concin N, Vanden Heuvel K, Slade N, Fischer M, Chalas E, Moll UM.

Int J Oncol. 2006 Oct;29(4):889-902.

PMID:
16964385
[PubMed - indexed for MEDLINE]
15.

The presence of an intronic deletion in p73 and high levels of ZEB1 alter the TAp73/DeltaTAp73 ratio in colorectal carcinomas.

Domínguez G, Peña C, Silva J, García JM, García V, Rodríguez R, Cantos B, Citores MJ, España P, Bonilla F.

J Pathol. 2006 Dec;210(4):390-7.

PMID:
17029218
[PubMed - indexed for MEDLINE]
16.

Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours.

Zwahlen D, Tschan MP, Grob TJ, Peters UR, Fink D, Haenggi W, Altermatt HJ, Cajot JF, Tobler A, Fey MF, Aebi S.

Int J Cancer. 2000 Oct 1;88(1):66-70.

PMID:
10962441
[PubMed - indexed for MEDLINE]
17.

Allelic expression and quantitative RT-PCR study of TAp73 and DeltaNp73 in non-Hodgkin's lymphomas.

Cuadros M, Ribas G, Fernández V, Rivas C, Benitez J, Martinez-Delgado B.

Leuk Res. 2006 Feb;30(2):170-7. Epub 2005 Aug 3.

PMID:
16083956
[PubMed - indexed for MEDLINE]
18.

Multiple isoforms of the tumor protein p73 are expressed in the adult human telencephalon and choroid plexus and present in the cerebrospinal fluid.

Cabrera-Socorro A, Pueyo Morlans M, Suarez Sola ML, Gonzalez Delgado FJ, Castañeyra-Perdomo A, Marin MC, Meyer G.

Eur J Neurosci. 2006 Apr;23(8):2109-18.

PMID:
16630058
[PubMed - indexed for MEDLINE]
19.

p73 Isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosis.

Díaz R, Peña C, Silva J, Lorenzo Y, García V, García JM, Sánchez A, Espinosa P, Yuste R, Bonilla F, Domínguez G.

Int J Cancer. 2008 Sep 1;123(5):1060-7. doi: 10.1002/ijc.23619.

PMID:
18546269
[PubMed - indexed for MEDLINE]
20.

BRCA1-associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinoma.

Ibrahim N, He L, Leong CO, Xing D, Karlan BY, Swisher EM, Rueda BR, Orsulic S, Ellisen LW.

Cancer Res. 2010 Sep 15;70(18):7155-65. doi: 10.1158/0008-5472.CAN-10-0668. Epub 2010 Aug 31.

PMID:
20807817
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk